APRIL SPRAGUE: Open Payments
NPI 1619693074 · LAWRENCE, KS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$258 in 12 payments from 9 companies in 2025. Trend: 2023 $145 · 2024 $261 · 2025 $258
Food & beverage: $258
| Company | Payments | Amount |
|---|---|---|
| Medtronic, Inc. | 1 | $71 |
| Amgen Inc. | 3 | $48 |
| Novo Nordisk Inc | 2 | $30 |
| Eisai Inc. | 1 | $27 |
| Aimmune Therapeutics, Inc. | 1 | $23 |
| Exact Sciences Corporation | 1 | $16 |
| ABBVIE INC. | 1 | $15 |
| GlaxoSmithKline, LLC. | 1 | $14 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $14 |
Products named: VENASEAL, OTEZLA, Leqembi, ZENPEP, Cologuard Collection Kit, QULIPTA, Ozempic, Wegovy.
Industry payments across KS — which companies pay providers there.
